EGFRvIII peptide

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-TP2703-10mg	10 mg	-	-	-	7 - 10 business days*		-
TGM-TP2703-50mg	50 mg	-	-	-	7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: EGFRvIII peptide is an epitope formed by the binding of the EGFRvIII mutant protein... more

Close menu

Product information "EGFRvIII peptide"

Description: EGFRvIII peptide is an epitope formed by the binding of the EGFRvIII mutant protein to MHC I molecules. Used alone or in combination with Flagellin B, this peptide can induce apoptosis (cell death) and trigger a specific immune response against glioblastoma. Target: Apoptosis. Smiles: [C@@H](CC1=CC=C(O)C=C1)(NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(C)C)N)=O)CCC(O)=O)=O)CCC(O)=O)=O)CCCCN)=O)CCCCN)=O)=O)CC(N)=O)=O)C(N[C@@H]([C@@H](C)C)C(O)=O)=O

Supplier:	TargetMol
Supplier-Nr:	TP2703

Properties

Conjugate:	No
MW:	1079.2 D
Formula:	C48H78N12O16

Database Information

Handling & Safety

Storage:	+4°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "EGFRvIII peptide"

Write a review